Use of a Product Containing the Cannabinoids CBD and THC as a Treatment Strategy for Alzheimer's Disease - Alzheimer's Disease and Cannabis Clinical Trial (DAZACANN) Open-Label Phase

Clinical trial NCT07091747 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07091747
Sponsor: Federal University of Latin American Integration
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease (AD)

Start date: 2025-04-07
Primary completion: 2025-12-12
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.